241 — Alibaba Health Information Technology Balance Sheet
0.000.00%
Last trade - 00:00
- HK$42.09bn
- HK$29.11bn
- CNY26.76bn
- 87
- 23
- 39
- 48
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,017 | 2,997 | 11,637 | 10,548 | 10,917 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 539 | 589 | 773 | 1,074 | 579 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,303 | 5,013 | 14,200 | 13,566 | 14,914 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.89 | 72.3 | 52.3 | 165 | 68.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 5,982 | 7,870 | 17,739 | 19,202 | 20,748 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,233 | 2,610 | 3,401 | 4,822 | 5,437 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3,187 | 2,601 | 3,437 | 5,104 | 5,574 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,795 | 5,269 | 14,302 | 14,098 | 15,174 |
Total Liabilities & Shareholders' Equity | 5,982 | 7,870 | 17,739 | 19,202 | 20,748 |
Total Common Shares Outstanding |